Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

In 2019, esketamine (Spravato), derived from ketamine, was approved by the FDA as a nasal spray for treatment-resistant depression. While ketamine therapy has shown promising results, its use ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

NRx Pharmaceuticals Inc. (NRXP), a pharmaceutical company with a market capitalization of $39.7 million, reported a significant reduction in operational losses and expenses in the fourth quarter ...

Add articles to your saved list and come back to them any time. Washington: An American Airlines jet’s engine has caught fire after diverting to land in Denver, forcing the evacuation of ...

It is a nasal spray that goes by the generic name of esketamine and the brand name of Spravato. Ketamine is a drug that has been used for many years to treat depression. Esketamine is a form of ...

FILE - Adnan Syed and his mother Shamim Rahman talk with reporters as they arrive at Maryland's Supreme Court in Annapolis, Md., Thursday, Oct. 5, 2023. (AP Photo/Susan Walsh, File) ...

This advertisement has not loaded yet, but your article continues below. SUMMERSIDE, P.E.I. — Mixed doubles curling is providing an opportunity for two household names in Canada to continue their ...